Histogenics to Explore Strategic Alternatives for NeoCart based on FDA Findings
Histogenics expects to suspend development of NeoCart, a tissue engineered implant, after FDA indicated that an additional clinical trial would...
The 2.5-day program was to provide increased cooperation among the company's departments....
Mr. Kollar will support product engineering and development, and spearhead expansion of plastic molding capabilities....
The company is a contract manufacturer of orthopaedic instruments and implants....
UPI is a contract manufacturer specializing in instruments and guide wires, primarily for spine....
Integra XT represents one of the first FDA-cleared devices indicated specifically for revision arthroplasty. The system features include an augmented...